Hepatic Fibrosis Clinical Trials

A listing of Hepatic Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 211 clinical trials
Featured trial
C2541013 MIRNA NASH  

is specifically designed to evaluate the effect of a range of doses of DGAT2i alone, and DGAT2i + ACCi, on resolution of NASH or improvement in liver fibrosis, as assessed histologically (via liver

  • 1372 views
  • 02 Aug, 2022
  • 44 locations
A Study to Test Whether Two Different Doses of BI 685509 Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

This study is open to adults with liver cirrhosis and high blood pressure in the portal vein (main vessel going to the liver). The purpose of this study is to find out whether a medicine called

  • 1 views
  • 25 Jul, 2022
  • 24 locations
  • 70 views
  • 25 Jul, 2022
  • 105 locations
Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)

cholangitis and suspected liver fibrosis

endoscopic retrograde cholangiopancreatography
ursodiol
magnetic resonance cholangiopancreatography
fibrosis
MRI
  • 32 views
  • 09 Jun, 2022
  • 52 locations
A Study to Test Safety and Efficacy of BI456906 in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

This study is open for men and women with a liver disease called nonalcoholic steatohepatitis (NASH) and liver fibrosis. The purpose of the study is to find out whether a medicine called BI

  • 71 views
  • 09 Aug, 2022
  • 171 locations
A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B (Piranga)

function and without significant fibrosis/cirrhosis. The platform design allows comparison of multiple NME combination therapies against a common control, and introduction of additional treatment arms at

chronic hepatitis
fumarate
fibrosis
tenofovir
combination therapy
  • 1 views
  • 20 Jul, 2022
  • 27 locations
Treatment of Hemochromatosis

other arm. Patients who have very high iron levels or an enlarged liver will be offered evaluation by the NIH Liver Service. Those judged to be at increased risk for cirrhosis may be advised to undergo

Accepts healthy volunteers
  • 114 views
  • 25 Jul, 2022
  • 1 location
A Study of ADR-001 in Patients With Liver Cirrhosis

This is a first-in-human Phase1/2 study of ADR-001, adipose-derived mesenchymal stem cells (AD-MSCs). The safety and preliminary efficacy are evaluated in Phase 1 in patients with liver

  • 40 views
  • 13 May, 2022
  • 2 locations
Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)

This is a Phase 1, open label, dose escalation clinical trial of human umbilical cord-derived mesenchymal stem cells for the treatment of decompensated cirrhosis. The purpose of this study is to

  • 0 views
  • 11 Aug, 2022
  • 1 location
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

A study to investigate the use of combination therapy with two investigational products for the treatment of adult patients with Nonalcoholic steatohepatitis (NASH).

  • 0 views
  • 02 May, 2022
  • 1 location